The next evolutionary step of rationing under Obamacare?


Obamacare won’t lead to rationing of medical care or available medicine? Hmmm… Looks like the FDA didn’t get the word on that. Or are we not supposed to know about this? From Breitbart’s Big Government:

“The FDA will make an 11am (EDT) announcement that it will begin denying Avastin to breast cancer patients but will graciously offer the creator of the drug a final show trial of a hearing in 60 days.

The FDA has never before limited access to a drug based upon cost considerations.  Yet there are some within the agency that are intent on breaking new ground to justify a rationing regime designed to drive down the cost of health care.  Avastin is the test case.  There is no evidence that the pending show trial will temper their enthusiasm for the rationing scheme.”

 

I guess the idea is for women to not get breast cancer so that they won’t increase the government’s costs of healthcare. According to biggovernment.com, the FDA is about to start limiting availability to Avastin which is a major drug in the treatment of late stages breast cancer. Let’s be honest, breast cancer is not an illness that effects women alone, men are capable of developing breast cancer, so this is not a target on women alone… this is a policy that impacts everyone regardless of gender. This IS rationing in its complete form.

Sadly, this goes hand in hand with breast cancer screening being delayed or even eliminated for women. As pointed out by the folks at Pharm-Aid blog:

“The U.S. Preventative Services Task Force (USPSTF) of HHS’ Agency for Healthcare Research and Quality (AHRQ) has launched an all-out jihad on women. The AHRQ and USPSTF are making some pretty radical recommendations: no mammography for women over age 74, a recommendation against mammo for women age 40-49 and mammo only every other year for women age 50-74. It’s not that there isn’t a compelling reason to skip on mammography, it’s that it costs too much. Under the new recommendations, a woman could develop advanced stage breast cancer and die by the time HHS would allow her to get screened.”

 

One has to wonder what’s next? Will there be rationing for blood pressure medicine? Rationing of dialysis treatment? Are we limiting the rationing to gender issues  age restrictions  cost concerns? For the full article on limiting Avastin, go to Exclusive: Sources Confirm FDA Moving Ahead with Rationing.

Advertisements
This entry was posted in Current Issues, Ethics, Government, Healthcare, Obamacare and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s